Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 6
1980 3
1981 3
1982 9
1983 10
1984 7
1985 10
1986 6
1987 2
1988 3
1989 5
1990 8
1991 2
1992 6
1993 8
1994 6
1995 7
1996 12
1997 19
1998 13
1999 17
2000 32
2001 18
2002 62
2003 32
2004 59
2005 63
2006 72
2007 70
2008 71
2009 64
2010 69
2011 63
2012 79
2013 82
2014 73
2015 61
2016 60
2017 64
2018 61
2019 65
2020 72
2021 73
2022 65
2023 66
2024 55
2025 32

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,567 results

Results by year

Filters applied: . Clear all
Page 1
Amisulpride: A Review in Post-Operative Nausea and Vomiting.
Kang C, Shirley M. Kang C, et al. Drugs. 2021 Feb;81(3):367-375. doi: 10.1007/s40265-020-01462-1. Epub 2021 Mar 3. Drugs. 2021. PMID: 33656662 Review.
Amisulpride intravenous (IV) injection (Barhemsys(); hereafter referred to as IV amisulpride), a selective dopamine receptor antagonist, is approved in the USA as a single IV infusion for the prevention and treatment of post-operative nausea and vomiting (PONV) in a …
Amisulpride intravenous (IV) injection (Barhemsys(); hereafter referred to as IV amisulpride), a selective dopamine receptor a …
Amisulpride augmentation therapy improves cognitive performance and psychopathology in clozapine-resistant treatment-refractory schizophrenia: a 12-week randomized, double-blind, placebo-controlled trial.
Zhu MH, Liu ZJ, Hu QY, Yang JY, Jin Y, Zhu N, Huang Y, Shi DH, Liu MJ, Tan HY, Zhao L, Lv QY, Yi ZH, Wu FC, Li ZZ. Zhu MH, et al. Mil Med Res. 2022 Oct 18;9(1):59. doi: 10.1186/s40779-022-00420-0. Mil Med Res. 2022. PMID: 36253804 Free PMC article. Clinical Trial.

Furthermore, compared with the placebo group, the amisulpride group showed an improved RBANS language score at week 12 (P(Bonferroni) < 0.001). Amisulpride group had a higher treatment response rate (P = 0.04), lower scores of CGI severity and CGI efficacy at wee

…
Furthermore, compared with the placebo group, the amisulpride group showed an improved RBANS language score at week 12 (P(Bonferroni) …
Amisulpride - is it as all other medicines or is it different? An update.
Hadryś T, Rymaszewska J. Hadryś T, et al. Psychiatr Pol. 2020 Oct 31;54(5):977-989. doi: 10.12740/PP/OnlineFirst/109129. Epub 2020 Oct 31. Psychiatr Pol. 2020. PMID: 33529280 Free article. Review. English, Polish.
Amisulpride is an antipsychotic available in Europe since 1990s, in Poland since 2000. Subsequent years brought to Polish market more second-generation compounds such as ziprasidone and aripiprazole. ...Amisulpride seems to have better outcome than classic and atypi …
Amisulpride is an antipsychotic available in Europe since 1990s, in Poland since 2000. Subsequent years brought to Polish market more …
Amisulpride.
[No authors listed] [No authors listed] Am J Health Syst Pharm. 2020 Nov 16;77(23):1917-1918. doi: 10.1093/ajhp/zxaa292. Am J Health Syst Pharm. 2020. PMID: 33196816 No abstract available.
Focus on amisulpride.
Green B. Green B. Curr Med Res Opin. 2002;18(3):113-7. doi: 10.1185/030079902125000363. Curr Med Res Opin. 2002. PMID: 12094819 Review.
Amisulpride is a second-generation antipsychotic, a substituted benzamide. It appears to be an effective agent in treating schizophrenia for what are characterised as positive and negative symptoms. ...There are interesting studies that point towards amisulpride's a …
Amisulpride is a second-generation antipsychotic, a substituted benzamide. It appears to be an effective agent in treating schizophre …
Amisulpride-Induced High Elevation in Prolactin Levels.
Prasannakumar A, Suhas S, Kumar V. Prasannakumar A, et al. Prim Care Companion CNS Disord. 2023 Jan 12;25(1):22cr03262. doi: 10.4088/PCC.22cr03262. Prim Care Companion CNS Disord. 2023. PMID: 36638538 Free article. No abstract available.
Amisulpride: progress and outcomes.
Lecrubier Y. Lecrubier Y. Curr Med Res Opin. 2002;18 Suppl 3:s18-22. doi: 10.1185/030079902125001083. Curr Med Res Opin. 2002. PMID: 12418608 Review.
Amisulpride maintains its efficacy when used for medium/long-term treatment as demonstrated in studies of up to 12 months. Amisulpride demonstrates greater improvement in controlling symptoms compared to haloperidol. ...
Amisulpride maintains its efficacy when used for medium/long-term treatment as demonstrated in studies of up to 12 months. Amisulp …
Efficacy of amisulpride on postoperative nausea and vomiting: a systematic review and meta-analysis.
Zhang LF, Zhang CF, Tang WX, He L, Liu Y, Tian DD, Ai YQ. Zhang LF, et al. Eur J Clin Pharmacol. 2020 Jul;76(7):903-912. doi: 10.1007/s00228-020-02869-1. Epub 2020 Apr 10. Eur J Clin Pharmacol. 2020. PMID: 32274525
Our aim was to assess the efficacy and safety of amisulpride for prevention and treatment of PONV through a systematic review and meta-analysis. ...The adverse event profile of amisulpride was generally similar to the placebo. CONCLUSION: Based on our findings, low- …
Our aim was to assess the efficacy and safety of amisulpride for prevention and treatment of PONV through a systematic review and met …
Amisulpride as an Augmentation Agent in Treatment Resistant Depression: A Case Series and Review of the Literature.
Rittmannsberger H. Rittmannsberger H. Psychiatr Danub. 2019 Jun;31(2):148-156. doi: 10.24869/psyd.2019.148. Psychiatr Danub. 2019. PMID: 31291218 Free article. Review.
Amisulpride (AMS) in low dosage has been used effectively for treatment of dysthymia. Yet there is a dearth of reports on its use as an augmentation agent in therapy-resistant depression. We deal with this issue presenting case reports and a review of the literature. The a …
Amisulpride (AMS) in low dosage has been used effectively for treatment of dysthymia. Yet there is a dearth of reports on its use as …
1,567 results